Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Favorites
Search by Category
Search by Format
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • Contains 10 Product(s)

    This curriculum was developed for attendees at the ACCC 40th National Oncology Conference. Content development was built around the 2023-2024 ACCC President’s Theme: (Re)Building the Oncology Workforce to Deliver Next Generation Care.

    Workforce issues around burnout, recruitment, and retention; financial challenges; and the move to value-based care require today’s oncology programs and practices to reimagine many of their strategies, operations, and services. How can we better use technology to support our workforce? Where can we streamline processes and procedures to realize greater efficiencies? What service lines can we expand or add to improve the patient experience, bolster our recruitment efforts, and grow our marketplace share? This Workforce Development Curriculum will help you create the positive change your clinicians, staff, and patients deserve.

  • Contains 6 Component(s)

    The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

    You must have an ACCC account in order to register for this course/webinar/webinar series ACORI Call to Action Summit: Activating Equity in Community Oncology Research.

    If You DO NOT Have An ACCC Account:

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
      • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
      • OSS at ACCC Members: Please use your state society login credentials.
      • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

    If You Have An ACCC Account:

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
    • You will be automatically redirected back to this course/webinar page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course/webinar . For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    image

    The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

    The Summit's interactive discussions focused around:

    • The importance of expanding access to clinical trials for patients of all background—to ensure the highest quality care
    • Strategies for engaging patients and their caregivers in shared decision-making around trial enrollment
    • Case studies to demonstrate solutions for optimizing accrual and overcoming barriers to trial participation
    • Tools and resources to support care teams, including budget forms, IRB templates, etc.
    • How to incorporate the patient perspective into trial design: insights for trial sponsors   

    This Summit is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register. Please click the "Registration Instructions" tab for more details.

    This Summit is part of the ACCC Community Oncology Research Institute and is supported by AbbVie, Amgen, AstraZeneca, Eisai, Genentech, Merck and Sanofi.

    Day 1: Panel Discussions

    Advancing Health Equity through Community Cancer Research
    Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, ASCO (Moderator)
    Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance
    Ysabel Duron, President/Executive Director, The Latino Cancer Institute
    Linda Burhansstipanov, MSPH, DrPH, Founder, Native American Cancer Research Corporation; President, Native American Cancer Initiatives, Incorporated

    Panel Conversation: Centering the Patient Perspective in Community Cancer Research
    Jeanne Regnante, Chief Health Equity and Diversity Officer, LUNGevity Foundation (Moderator)
    Shonta Chambers, MSW, Executive Vice President, Patient Advocate Foundation
    Venus Ginés, MA, P/CHWI, CEO and Founder, Día de la Mujer Latina
    Rodney Haring, PhD, MSW, Director, Center for Indigenous Cancer Research, Roswell Park Comprehensive Cancer Center

    Fostering Readiness for Community Cancer Research
    Nadine Barrett, PhD, MA, MS, Director, Office of Health Equity and Disparities, Duke Cancer Institute; Director, Duke Community Connections Core, Duke CTSA (Moderator)
    Robert Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center
    Nina Bickell, MD, MPH, Co-Lead, Cancer Prevention and Control, Tisch Cancer Institute
    Randall A. Oyer, MD, Medical Director, Ann B. Barshinger Cancer InstitutePenn Medicine Lancaster General Health; ACORI Chair

    Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development
    Lola A. Fashoyin-Aje, MD, MPH, Deputy Division Director, FDA Oncology Center of Excellence
    Jennie R. Crews, MD, MMM, FACP, Medical Director, SCCA Network & Community Sites, Seattle Cancer Care Alliance
    Erin Williams MBA, Associate Director, SCCC Clinical Research Operations, University of Texas Southwestern Medical CenterSimmons Comprehensive Cancer Center
    Racquel Racadio, MPH, Senior Manager, Diversity and Representation in Clinical Research, Amgen

    Day 2: Breakout Discussions

    SU2C Special Session
    Olajide Williams, MD, Founder and President, Hip Hop Public Health
    Sung Poblete, PhD, RN, Chief Executive Officer, SU2C

    Harnessing the Power of Community Partnerships to Improve Patient Accrual
    Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance

    Building Research Capacity to Strengthen Cancer Trials in the Community
    Lola A. Fashoyin-Aje, MD, MPH, Deputy Division Director, FDA Oncology Center of Excellence

    Incorporating the Patient Perspective into Trial Design
    Carla Strom, MLA, Assistant Director, Operations, Wake Forest Baptist Health Comprehensive Cancer Center

    ACORI Call to Action Summit's Executive Summary

    Developed as an overview of the action items co-developed by the Summit participants for ACCC and oncology programs and practices, as well as other stakeholders, the action items detailed in the Executive Summary are intended to serve as foundational resources in support of the ACORI stakeholders in their work to improve equity and inclusion in research and diversify clinical trials.

    Summit Resource Library 

    Curated to advance your learning, this resource library includes slides from each day of the Summit, assessment tools, executive summaries, and more.

    Clinical Research Terms Glossary 

    ACCC has created a digital glossary of clinical research terms that will help to establish a standardized understanding across cancer care team members and can serve as a tool to improve patient education and encourage shared decision-making conversations.

    ASCO-ACCC Collaborative

    ASCO and ACCC have joined forces to ensure that cancer treatment trials better reflect the diversity of cancer populations. The goal of the collaboration is to establish practical strategies and solutions to help increase participation in cancer treatment trials, with a focus on increasing clinical trial participation in patients from historically underrepresented racial and ethnic communities.

    Seventy five research sites have signed on to participate in the pilot project, which aims to help ensure racial and ethnic diversity among clinical trial participants and support for clinicians so they are able to routinely offer clinical trials to all eligible patients.

    [PODCAST] Mini-Podcast: Improving Community Clinical Trial Participation

    Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.

    Guest: Alex Spira, MD, PhD, FACP, Medical Oncologist; Director, VCS Research Institute & Phase I Trial Program, Virginia Cancer Specialists

    [ACCCBuzz Blog] ACCC Pursues Health Equity Through ACORI

  • Contains 4 Component(s)

    Listen to perspectives on how to effectively support patients diagnosed with acute lymphocytic leukemia (ALL) throughout the care journey from multidisciplinary cancer team members and a patient representative.

    Listen to perspectives on how to effectively support patients diagnosed with acute lymphocytic leukemia (ALL) throughout the care journey from multidisciplinary cancer team members and a patient representative. Panelists define cohesive communication between the care team and the patient, describe elements required to deliver compassionate care and introduce cost awareness, and discuss how to present treatment risk-benefit analysis. If you have any questions along the way please contact Monique Dawkins, Assistant Director, Provider Education for ACCC.

    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.  

     If You DO NOT Have an ACCC Account: 

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page. 
    • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.  
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.  
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link. 
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course! 

    If You Have an ACCC Account: 

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button. 
    • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course! 

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!  

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar. 

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

  • Contains 2 Component(s)

    Sign-up for the third webinar in a 6-part series, titled, “Addressing the High Cost of Radiology Services.”

    You must have an ACCC account in order to register for this course/webinar/webinar series.

    If You DO NOT Have An ACCC Account:

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
      • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
      • OSS at ACCC Members: Please use your state society login credentials.
      • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

    If You Have An ACCC Account:

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
    • You will be automatically redirected back to this course/webinar page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course/webinar . For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    In the third webinar, we heard from Jennifer Paquet, RN, BSN, Financial Assistance Patient Care Coordinator Supervisor from Bassett Cancer Institute and Aimee Hoch, MSW, LSW, Oncology Financial Navigator from Grand View Health Cancer Center. We discussed barriers to radiology prior authorizations and provide insights on how to address them.

    Jennifer Paquet, RN, BSN

    Bassett Cancer Institute

    Aimee Hoch, MSW, LSW

    Oncology Financial Navigator

    Grand View Health Cancer Center

    Aimee Hoch, LSW, OSW-C, is a Masters Level Social Worker with 20 plus years of experience in both healthcare and behavioral health. She earned her MSW from Fordham University Lincoln Center. A Financial Navigator for the Oncology Program at Grand View Health, Aimee is an advocate for individuals diagnosed with cancer by meeting them with empathy and connecting them with resources to support them during their most vulnerable times.

    Aimee is a consultant for the Cancer Support Community as a Financial Navigation specialist and is a member of their Biosimilar Advisory Board. She is an active member of the Association of Community Cancer Center’s (ACCC) Financial Advocacy Network Advisory Committee and Voice Task Force.  She speaks about Financial Toxicity and the role of Financial Navigation in cancer care.  Aimee has been a guest on Cancer Buzz TV, Patient Power, and WDVR. She has been featured in publications including Breastcancer.org, Patient Power, and ACCC’s Financial Advocate Spotlight. Aimee has contributed to ACCC’s Patient Assistance and Reimbursement Guide and OncoLink News. 

  • Contains 4 Component(s)

    The ACCC Alternative Payment Model Coalition builds off the success of Oncology Care Model (OCM) Collaborative​ by addressing the broader interest in alternative payment models (APMs) beyond the OCM.

    The ACCC Alternative Payment Model Coalition builds off the success of Oncology Care Model (OCM) Collaborative by addressing the broader interest in alternative payment models (APMs) beyond the OCM. 

    Please join us for two live webinars where you will have the opportunity to explore the future of alternative payment modelsSpeakers will discuss challenges, opportunities, and pitfalls that have been encountered and how programs and practices considering changing to a value-based model approach can operationalize successfully. 

    The Future of Alternative Payment Model Participation: Transitioning from the Oncology Care Model (OCM) to the Oncology Care First (OCF) Model 

    Thursday, February 25, 2021, 3:00 - 4:00 PM EST

    Fred Bentley, MPP, MPH, Managing Director, Avalere Health 

    Blair Burnett, Consultant, Avalere Health 

    Tom Gallo, MS, MDA, Executive Director, Virginia Cancer Institute 

    How has participation in alternative payment models (APMs) changed since the onset of the COVID-19 pandemic? How can oncology practices benefit from enrollment and potential future models (i.e., OCM, OCF, Radiation Oncology Model etc.)? What support services are recommended for cancer programs currently enrolled in APMs or considering enrollment in future models? 

    2021 Medicare Advantage and Managed Medicaid Updates: Where Are We Headed? 

    Thursday, March 11, 2021, 4:00 – 5:00 PM EST

    Tom Gallo, MS, MDA, Executive Director, Virginia Cancer Institute

    Tom Kornfield, MPP, Senior Consultant, Avalere Health

    Fred Bentley, MPP, MPH, Managing Director, Avalere Health 

    How are Medicare Advantage and state Medicaid benefits changing in 2021? What should oncology practices and providers understand and what impact will these changes have on practice operations? 

    These webinars are developed in collaboration with Avalere Health. 

    The ACCC Alternative Payment Model Coalition is supported by Amgen, Merck & Co, Inc., and Takeda. 

    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.  

     If You DO NOT Have an ACCC Account: 

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page. 
    • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.  
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.  
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link. 
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course! 

    If You Have an ACCC Account: 

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button. 
    • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course! 

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!  

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar. 

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    Tom Gallo, MS, MDA

    Executive Director, Virginia Cancer Institute

    Thomas A. Gallo, MS, MDA, is executive director of the Virginia Cancer Institute in Richmond, Virginia. In this role, he manages all aspects of a 24-provider medical oncology practice with 7 medical offices, ambulatory infusion centers, laboratories, and more than 200 employees. Among his responsibilities are strategic planning, operations, financial management, personnel management, and purchasing.

    Mr. Gallo has been an active member of the Association of Community Cancer Centers (ACCC) for more than 10 years. He served as ACCC President from 2018-2019. Currently, he also serves on ACCC’s Governmental Affairs Committee, which he previously chaired. He has presented at a number of ACCC Annual Meetings and has previously served on the ACCC Board of Trustees (2004-2005).

    In addition to his involvement with ACCC, Mr. Gallo is a member of the Board of Directors of MD Value Care, an ACO of independent physician practices; past president of the Executive Committee of the MGMA Administrators in Oncology-Hematology Assembly (AOHA); a current member and former president of the Board of Directors of the Virginia Association of Hematologists and Oncologists (VAHO); and a former board member of the Community Oncology Alliance.

    Prior to entering the healthcare field, Mr. Gallo was a commercial banker with Marine Midland Bank in New York City and Central Fidelity Bank in Richmond, Virginia.

    He received a BA in Economics from the College of William and Mary in Williamsburg, Virginia, and an MS in Finance and a Master of Decision Analytics (MDA) degree from Virginia Commonwealth University, where he was a Dean’s Scholar.

    Fred Bentley, MPP, MPH

    Managing Director, Avalere

    As an expert in fields ranging from payer strategy to hospital–physician alignment and post-acute care, he has worked with providers, including integrated delivery networks, academic medical centers, post-acute providers, and long-term care organizations as well as national and regional health plans. Over the past 5 years, his work has focused on supporting health systems engage in Medicare and Medicaid payment and delivery system transformation initiatives.

    Prior to joining Avalere, Fred was a principal in the Accountable Care Solutions practice at The Chartis Group. In this role, he worked with leading hospitals and health systems in developing strategic roadmaps to guide their clinical innovation, population health, and cross-continuum integration initiatives. He also served as a managing director with The Advisory Board Company, managing a team of consultants and analysts who supported provider organizations ranging from physician groups and health systems to post-acute care providers.

    Fred holds an MPP and MPH from the University of California, Berkeley, and a BA in political science from Haverford College.

    Blair Burnett

    Consultant

    Avalere Health

    With experience in provider associations, management consulting, and advocacy groups, Blair assists clients with analysis on a range of federal health policy topics. Blair has particular expertise in policy issues related to oncology and Medicare Part B.

    Prior to joining Avalere, Blair was senior policy analyst at the Association of Community Cancer Centers where she oversaw the legislative and regulatory advocacy priorities at the federal and state level for over 2,500 cancer care programs in the association’s membership. Prior to that, Blair was a healthcare analyst with Huron Consulting Group where she assisted clients in care access and revenue cycle projects.

    Blair has a BA in public policy with a minor in information science from the University of North Carolina at Chapel Hill.

    Tom Kornfield, MPP

    Senior Consultant, Avalere Health

    Tom Kornfield provides analytical support and strategic advice for clients on Medicare Advantage risk adjustment and payment, and on Part D issues.  He has over 20 years of public and private sector experience in Medicare Advantage and Part D payment policy.

    Prior to joining Avalere, Tom served as a vice president of Medicare policy at America’s Health Insurance Plans (AHIP). During his tenure at AHIP, he led risk adjustment policy discussions with plan members and external stakeholders. Additionally, he oversaw research and analyses about the impacts of Medicare Advantage (MA) payment and risk adjustment policies.  He also helped to lead work looking at the distribution of rebates among Part D plans and contributed to analyses of the impacts of restructuring the Part D benefit.

    Tom also spent 10 years working at the Centers for Medicare & Medicaid Services (CMS), where he held a variety of positions focused on MA and Part D payment policy. Specifically, Tom analyzed MA bids and payments and changes in MA payment rates, and he created a policy to allow for 5-star MA plans to market and enroll year-round.

    Tom holds a graduate degree from the University of Michigan’s School of Public Policy. His undergraduate degree is from Hamilton College.

  • Contains 15 Component(s)

    This seven-part e-module series covers the domains of the Alternative Payment Model (APM) Readiness Assessment, outlines specific next steps and action items your organization can take to begin APM program implementation, and provides real-life examples that correspond to each topic.

    As a result of market pressures to expand value-based healthcare in oncology, the Association of Community Cancer Centers (ACCC) developed the Alternative Payment Model Coalition (APMC) to gain important insights into how alternative payment models (APMs) impact cancer delivery. This educational initiative will focus primarily on providing education about APMs and other value-based programs in cancer care.

    This seven-part e-module builds on the Oncology Alternative Payment Model Readiness Assessment that was first introduced at the APMC Workshop during the ACCC 37th [Virtual] National Oncology Conference. If your cancer center is ready to begin or expand its journey to value-based care—but you are not sure how to get started—these modules can help. In each session, we will dive deeper into each domain and help you determine what is next for your cancer center. We will outline specific next steps and action items your organization can take to begin APM program implementation. In addition, we will also provide real-life examples that correspond to each topic.

    Although all seven modules work together, we intentionally designed them so you can view each module independently in short bursts, as they are each 15 to 20 minutes long.

    The e-modules will address:
    •How to evaluate market feasibility.
    •What entails a comprehensive provider network.
    •The key components of care delivery transformation.
    •How robust technology can support your value-based care delivery models.
    •The types of effective payment models that define value-based payments.
    •How to align provider compensation.
    •Why a strong organizational foundation is essential

    The ACCC Alternative Payment Model Coalition is supported by Amgen, Merck & Co, Inc., and Takeda.

    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.  

     If You DO NOT Have an ACCC Account: 

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page. 
    • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.  
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.  
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link. 
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course! 

    If You Have an ACCC Account: 

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button. 
    • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course! 

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!  

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar. 

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    Purvi Bhatt, MBA

    ECG Management Consultants

    Purvi is highly regarded for her practical knowledge of reimbursement strategies and her track record of executing managed care contracting plans that result in significant revenue enhancements. A valued member of ECG's Contracting and Reimbursement practice, for 10 years Purvi has provided extensive executive-level leadership to physician groups, hospitals and health systems in the area of payor contracting, where an organization's portfolio of commercial contracts is critical to revenue viability. She has helped clients optimize their payor portfolios, achieving top-line revenue gains of 10% to 20%. Her clients appreciate her ability to understand the critical, financial, operational, and other business terms that typically affect contract performance.  

    Purvi also works closely with providers and health systems as they transition from volume- to value-based delivery systems, analyzing quality and financial data; facilitating stakeholder discussions regarding a culture of collaboration, creativity, and accountability; and developing accountable care organization/delivery-based strategies.

    Valerie Csik, BS, MPH, CPPS

    Director, Quality and Care Transformation Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System

    Valerie Csik, MPH, CPPS is the Director of Quality and Care Transformation for the cancer service line at Thomas Jefferson University Health System. She oversees oncology quality initiatives in the Sidney Kimmel Cancer Center, and her responsibilities include managing the cancer center’s participation in the Centers for Medicare and Medicaid Services (CMS) Oncology Care Model program, as well as aligning various shared savings programs and quality initiatives to improve operations and reduce care variation.  

     Since 2005, Csik has been a dedicated volunteer with the American Cancer Society. She has held various leadership positions, serves as the Chair of the Greater Philadelphia Volunteer Leadership Council, and was the Founding Chair of the Young Professionals of the American Cancer SocietyPhiladelphia Chapter 

    Csik started her career at Thomas Jefferson University and then joined the Patient Safety Organization partnering with healthcare systems around the world to evaluate and improve patient safety culture. Valerie returned to Jefferson as Project Director in the department of medical oncology. Her education includes a bachelor’s degree in Healthcare Administration from the University of Scranton and masters degree in Public Health from Thomas Jefferson University. She is also a graduate of the American Hospital Association (AHA) and National Patient Safety Foundation (NPSF) Comprehensive Patient Safety Leadership Fellowship and is a Certified Professional of Patient Safety. 

    Anne Marie Rainey, MSN, RN, CHC

    Director of Quality and Value-based Care

    Clearview Cancer Institute

    Anne Marie Rainey, RN, MSN, CHC, is the Director of Quality and Value-based Care at Clearview Cancer Institute in Huntsville, Alabama. She has previous experience in government quality reporting as a contractor for the Centers for Medicare Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC)

    After obtaining her Master of Nursing in Clinical Leadership and Administration, Rainey transitioned to the community oncology setting. Her work interests include quality metrics analysis, program implementation, health policy, and advocacy for community oncology.  

    Amy Ellis

    Chief Quality Officer, Northwest Medical Specialties, PLLC (NWMS)

    Amy Ellis is the director of Quality and Value Based Care at Northwest Medical Specialties, PLLC (NWMS). In this role, she oversees NWMS strategic practice initiatives and value-based care programs including the Oncology Care Model, Oncology Medical Home and various commercial payment models. Ms. Ellis works to continually transform the way care is provided to patients by utilizing innovative tools such as artificial intelligence, care management technology, population health technology, continual process improvement, and data analysis. 

    She brings 14 years of healthcare experience, including outpatient radiology and clinical oncology research. Amy has been recognized for her work on the Payment Reform Committee of the Community Oncology Alliance (COA), her active involvement in the Association of Community Cancer Centers (ACCC) Conference Planning Task Force and practice initiatives, as well as her value-based care leadership with the Quality Cancer Care Alliance Network and Washington state oncology initiatives. She is passionate about the quality of care provided to patients and strives to improve outcomes and the patient experience. 

    In 2019, Amy received a HemOnc Today’s Next Gen Innovator award for her forward-thinking approach in cancer care.

    Mark Liu, MHA

    Director, Strategic Initiatives

    Mount Sinai Health System

    Mark Liu is the Director of Strategic Initiatives for the oncology service line at the Mount Sinai Health Systeman eight-hospital integrated health system in all five boroughs of New York City. He works closely with senior leadership to develop long-term strategy, while collaborating to drive critical projects to completion. 

    He first joined Mount Sinai as part of a team to facilitate the build of Mount Sinai Health Partners, a new entity advancing population health within the health system. Prior to thisLiu managed ambulatory care operations at Memorial Sloan Kettering Cancer Center across nine different solid and hematologic cancers during his eight-year tenure. 

    He received a Bachelor of Science, double majoring in Integrated Neuroscience and Sociology, from Binghamton University.  Liu was selected as a 2008 fellow for the New York University (NYU) Leadership Initiative and NYU Wagner Fellowship for Emerging Leaders in Public Service. He is currently completing his Master of Healthcare Administration at the Mailman School of Public Health at Columbia University.

    Jordan Brozyna, BBA

    ECG Management Consultants

    Jordan’s diverse background in managed care work gives her a unique perspective in delivering results to clients. Utilizing her strong analytics skills, Jordan is able to convey thoughtful, data-driven solutions for both traditional contracting engagements and progressive value-based care initiatives. Through her experience, Jordan has developed a deep understanding of the nuances of healthcare industry as she has worked with hospitals, physician groups, and ambulatory surgical centers. Specifically, she has established expertise in the development and implementation of alternative payment models (APMs). She is passionate about payment reform, new delivery models, and the healthcare system of the future. Jordan will work to ensure your organization is on the right path to success.

    Summary of Expertise

    Since joining ECG over five years ago, Jordan has worked with several health systems to develop, implement, and maintain bundled payment programs. Specifically, she supports hospital and physician leadership in care process redesign and care coordination improvement. Additionally, Jordan has expertise in bundled payment pricing analytics, especially for providers wishing to pursue commercial or employer-based bundles. Recently, Jordan worked with a health system to achieve more than $5 million in savings over three years through the implementation of a bundled payment initiative.

    Jordan is also regarded for her work with clients to optimize their payer portfolios and develop reimbursement strategies. Partnering with provider groups, she works side-by-side with physicians and administrators to help them increase revenue and foster stronger payer relationships. Recently, Jordan helped a pediatrics practice achieve a 10% revenue increase across their top commercial payers.  Furthermore, as the healthcare industry experiences a significant shift from inpatient to ambulatory care, Jordan has worked with ASCs to help them bring new and unique services to market. Specifically, she works with payers to help them understand the value of these novel procedures and, as a result, establish reimbursement for the ASCs.


  • Contains 3 Component(s)

    Oncology state society leaders from the Appalachian Community Cancer Alliance share an introduction to the Alliance, their insights into the unique needs of the Appalachian region and beyond, how the Alliance is responding and how you can get involved.

    You must have an ACCC account in order to register for this course/webinar/webinar series.

    If You DO NOT Have An ACCC Account:

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
      • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
      • OSS at ACCC Members: Please use your state society login credentials.
      • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

    If You Have An ACCC Account:

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
    • You will be automatically redirected back to this course/webinar page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course/webinar . For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    The Appalachian Community Cancer Alliance, established in 2021 by six oncology state societies, aims to improve cancer care in rural Appalachia where cancer is diagnosed at a 32% higher rate than that of the U.S. national average. The Alliance invites you to join in this webinar and learn more about its mission, obtain insight into the unique needs of the Appalachian region, discuss how the Alliance is responding to those needs, and how you can participate and/or stay abreast of Alliance progress and resources.

    Aasems Jacob, MD, FACP, FAPCR

    Hematologist/Oncologist, Leonard Lawson Cancer Center, Pikeville Medical Center Adjunct Faculty University of Pikeville Pikeville, KY

    Aasems Jacob, MD, FACP, FAPCR, is a Hematologist/Oncologist at the Leonard Lawson Cancer Center at the Pikeville Medical Center and Adjunct Faculty at University of Pikeville. His clinical and research interests in the specialty include thoracic oncology, immunotherapy, and healthcare disparities.

    Dr. Jacob completed medical school from University of Kerala, India and residency in Internal Medicine from Monmouth Medical Center, NJ. His fellowship in Hematology/Oncology was completed at University of Kentucky where he served as the Chief Fellow.

    Richard Ingram, MD

    President, Virginia Association of Hematologists and Oncologists; Medical Oncologist, Shenandoah Oncology

    Richard Michael Ingram, MD, is a physician partner at Shenandoah Oncology in Winchester, VA, and the President of the Virginia Association of Hematology Oncology. He serves patients in the Northern Shenandoah Valley and surrounding communities in Virginia, West Virginia and Maryland. Dr. Ingram also serves on the Board of Directors of the Community Oncology Alliance.

    Dr. Ingram received his medical degree from the State University of New York Health Sciences Center at Syracuse. He completed an internship and residency at the University of Virginia. 

    Nicole L. Stout DPT, CLT-LANA, FAPTA

    Research Assistant Professor West Virginia Cancer Institute, Research Assistant Professor West Virginia University School of Public Health Morgantown, WV

    Dr. Nicole L. Stout is a research assistant professor at the West Virginia University Cancer Institute and a research assistant professor at the West Virginia University School of Public Health in Morgantown, WV.

    Dr. Stout’s research interests include cancer rehabilitation and survivorship care. She studies implementation of survivorship supportive care services in cancer care delivery and oversees WVUCI’s survivorship research agenda, quality improvement initiatives, and supportive care infrastructure development. Her research focus is on development and implementation of cancer care delivery models and interventions that prevent functional decline during and after cancer care. Key funded components of her research agenda include (i) studying the implementation of prospective, risk stratified functional assessment and symptom management strategies across cancer care delivery, (ii) studying community outreach and engagement strategies with primary care providers to enable implementation of cancer prevention and control interventions

    Dr. Stout received her Bachelor of Science degree from Slippery Rock University of Pennsylvania in 1994, a Master of Physical Therapy degree from Chatham University in 1998 and a clinical Doctorate in Physical Therapy from Massachusetts General Hospital Institute of Health Professions in 2013. She has a post graduate certificate in Health Policy from the George Washington University School of Public Health.

    David S. Switzer MD, FAAFP

    Medical Director, Population Health Valley Health System, Luray, VA

    David Switzer MD, FAAFP, is the Medical Director of Population Health at Valley Health System in Luray, VA. He also provides primary care services in Page County, VA. Dr. Switzer also serves as the President of the Board of the Page Free Clinic in Luray, VA.

    Dr. Switzer completed his undergraduate studies, medical school, and family medicine residency at the University of Virginia.    

    Ashley Lile, MPH, LSSGB (Moderator)

    Program Manager, ACCC

  • Contains 9 Component(s)

    Testing for measurable residual disease can shape treatment choices and affect overall outcomes for patients with B-cell acute lymphoblastic leukemia. Unfortunately, routine MRD testing is variable. This three-part webinar series is aimed at building capacity to implement, expand, and sustain MRD testing for patients with adult B-cell ALL at cancer programs and practices of all resource levels.

    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.  

    If You DO NOT Have an ACCC Account:  

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.  
    • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.   
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.   
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.  
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course!

    If You Have an ACCC Account: 

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.  
    • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course!  

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!   

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webinar. 

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.  

    This three-part webinar series is aimed at building capacity to implement, expand, and sustain measurable residual disease (MRD) testing for patients with B-cell acute lymphoblastic leukemia (ALL) at cancer programs and practices of all resource levels.

    When you register, you will automatically be registered for all three webinars. You will also receive access to all the on-demand recordings and slides once they become available.

    A Roadmap for MRD Testing in B-cell ALL: Lay the Groundwork (Part I)

    Thursday, November 18, 2021, 12:00 - 12:30 PM EST

    Learn about the basics of MRD testing and how to assess your program’s buy-in to implement or expand MRD testing. 

    Speakers 

    • Haifaa Abdulhaq, MD, Clinical Professor of Medicine, Hematology/Oncology Director of Hematology, UCSF Fresno 
    • Nikki Yuill, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society (Moderator)

    A Roadmap for MRD Testing in B-cell ALL: Prepare the Care Team (Part II) 

    Thursday, December 2, 2021, 12:00 - 12:30 PM EST 

    Learn how clinical and non-clinical staff are involved in MRD testing, how to assess your program’s communication and staffing needs, and how to develop an implementation plan.  

    Speakers: 

    • Kelly Terrell, MBA, BSN, RN, BMTCN, Patient Care Manager, Operations, Division of Leukemia and Stem Cell Transplantation, Barnes-Jewish Hospital 
    • Nikki Yuill, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society (Moderator) 

    A Roadmap for MRD Testing in B-cell ALL: Implement the Initiative & Evaluate Your Progress (Part III) 

    Thursday, December 9, 2021, 12:00 - 12:30 PM EST

    Learn how to assess your clinical workflow needs to implement MRD testing and how to evaluate, pilot, and refine MRD testing in your program. 

    Speakers: 

    • Rima Koka, MD, PhD, Associate Professor, University of Maryland School of Medicine; Associate Professor, Section of Hematology, Department of Pathology, University of Maryland Medical Center 
    • Nikki Yuill, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society (Moderator) 


    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register. Please click the "Registration Instructions" tab for more details.

    This webinar is part of the Integration of MRD Testing: A Pathway for Patients with B-Cell Acute Lymphoblastic Leukemia education project. Funding & support provided by Amgen.

    Haifaa Abdulhaq, MD

    Clinical Professor of Medicine, Hematology/Oncology Director of Hematology

    UCSF Fresno

    Haifaa Abdulhaq, M.D., is board certified in hematology and medical oncology with expertise in malignant hematology including lymphoproliferative neoplasms, myeloproliferative neoplasms, acute leukemia, multiple myeloma, and has an interest in stem cell transplantation.

    Dr. Abdulhaq is a member of the American Society of Hematology, the American Board of Internal Medicine, the American Society of Clinical Oncology, and the American Society of Blood and Bone Marrow Transplantation. She is a board member of the Leukemia and Lymphoma Society, Central California Chapter, and she is the chair of the Cancer Committee at Community Medical Centers in Fresno, CA. Dr. Abdulhaq has special interest in medical education and is a recipient of the Henry Kaiser Award for Excellence in Teaching at UCSF. She is also interested in clinical research, and she serves as the principal investigator on many clinical trials on malignant hematology.

    Dr. Abdulhaq completed a residency in internal medicine and a fellowship in hematology and oncology at Western Pennsylvania Hospital and Allegheny General Hospital in Pittsburgh, PA.

    Rima Koka, MD, PhD

    Associate Professor, University of Maryland School of Medicine; Associate Professor, Section of Hematology, Department of Pathology

    University of Maryland Medical Center

    As a pathologist, Madhurima Koka, MD, PhD, offers a unique perspective and new ideas on ongoing clinical trials based on her experience with morphology, immunophenotype, and molecular genetics. Furthermore, through her experience as a basic scientist, Dr. Koka learned the nuances of study design and data interpretation that allow for the application of scientific techniques to diagnosis and treat malignancies. She has particular interest in understanding the utility of molecular techniques in diagnosis and prognostication in lymphomas and leukemias. 

    Dr. Koka works closely with hematologists and oncologists on various clinical-translational studies, which include the application of novel compounds in the treatment of acute leukemia and lymphomas. She is particularly interested in the use of immune-modulating agents and targeted immunotherapies in the treatment of these malignancies. Additionally, Dr. Koka is a co-investigator on a Bill & Melinda Gates Foundation-funded grant looking at the causes of childhood mortality in Mali, Africa. Dr. Koka has also provided pathologist support to numerous National Institutes of Health (NIH)-funded investigations through the University of Maryland cancer tissue repository.  

    Kelly Terrell, MBA, BSN, RN, BMTCN

    Clinical Program Manager, Division of Leukemia and Stem Cell Transplantation

    Barnes-Jewish Hospital

    Kelly Terrell, MBA, BSN, RN, BMTCN, is the nurse manager for the Stem Cell Transplant and Cell Therapy program at Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis, Missouri.

    She has nine years of experience in oncology, five of which have been in nursing leadership. Terrell has sat on several nurse advisory boards and has also had several abstracts published in the American Society of Hematology’s (ASH) peer-reviewed journal, Blood.

    Kelly earned her bachelor of science degree from Goldfarb School of Nursing at Barnes-Jewish Hospital and her master of business administration degree from Webster University.

    Nikki Yuill, LCSW (Moderator)

    Director, Information Resource Center

    The Leukemia & Lymphoma Society

    Nikki Yuill is a bilingual (Spanish) Clinical Oncology Social Worker with more than 25 years of healthcare and oncology experience. She attended Purdue University in Indiana for her undergraduate degrees, and she completed her graduate work at the University of Texas at Austin.

    Yuill has experience in blood cancers, solid tumors, andhematopoietic stem cell transplantation. She has extensive knowledge of and experience in advocacy, education, and support of blood cancer patients and their families. Yuill has a particular interest in adolescent and young adult cancer care, healthcare disparities, and serving the Latinx community.

    Yuill is the director of the Information Resource Center at The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. Yuill is a proud member of the AOSW (Association of Oncology Social Workers). In 2020 she was awarded the AOSW LLS Oncology-Hematology Lifetime Achievement Award because of her longstanding efforts on behalf of cancer patients.

  • Contains 7 Component(s)

    Tune into sessions from the ACCC Big Data in IO Workshop, where expert faculty will delve into role of data in managing immune-related adverse events; applications of clinical trial and real-world data; the evolving integration of molecular data and patient-reported outcomes; and how new technologies will impact the future of data in immuno-oncology.

    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.  

     If You DO NOT Have an ACCC Account: 

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page. 
    • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.  
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.  
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link. 
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course! 

    If You Have an ACCC Account: 

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button. 
    • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course! 

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!  

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar. 

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    On Wednesday, November 18, 2020, the Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute convened its Big Data in IO Workshop. This three-hour virtual event included both didactic and interactive sessions about the application of big data in immuno-oncology (IO), particularly as it relates to clinical research and its real-world implementation.

    Recordings of the opening and closing panels, “Data in Practice” and “Future Applications of Data in Immuno-Oncology.” are available for on-demand viewing. You will hear from experts in the field and other members of multidisciplinary cancer care team around the following topics:

    · The role of data in managing immune-related adverse events

    · The applications of clinical trial and real-world data

    · The evolving integration of molecular data and patient-reported outcomes

    · New technologies and the future of data in IO

    Lee Albacker, PhD

    Foundation Medicine

    Dr. Albacker leads immunotherapy biomarker research at Foundation Medicine. His team has studied how the natural history of tumor-immune interactions affects checkpoint inhibitor response, leading to the discovery of STK11 as a negative predictor of response. Using big-data approaches, his team is beginning to understand the complex interplay of multiple checkpoint inhibitor biomarkers. Dr Albacker was classically trained in immunology as a graduate student at Harvard University and then went on to study cancer genomics as a post-doc in the Harvard Department of Systems Biology. 

    Firas El Chaer, MD

    Assistant Professor, UVA Health

    Dr. El Chaer is an Assistant Professor of Medicine who specializes in hematology and oncology. His clinical areas of interest are acute leukemia, chronic leukemia, myelodysplastic syndrome, myeloproliferative disorders, aplastic anemia, clonal hematopoiesis, and blood disorders. His research focuses on improving outcomes for acute leukemia in adults by focusing on targeted therapies and overcoming resistance mechanisms. 

    Dr. El Chaer attended medical school at the University of Balamand in Beirut, Lebanon, and completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, in EnglewoodNew Jersey, where he served as chief resident from 2013 - 2014. He then completed a fellowship in infectious diseases for immune-compromised cancer patients at the combined program of Baylor College of Medicine and MD Anderson Cancer Center in Houston, Texas.  

    Dr. El Chaer pursued a fellowship in hematology and oncology with a focus on blood disorders and also completed a built-in fellowship in stem cell transplantation at the University of Maryland School of Medicine, where he served as a chief fellow from 2018 - 2019. 

    Matthew Hellman, MD

    Associate Attending, Memorial Sloan Kettering Cancer Center

    Dr. Hellman is currently an Associate Attending at Memorial Sloan Kettering Cancer Center in New York. He works in the Thoracic Oncology Service as well as the Early Drug Development Service. His academic focus is clinical and translational research related to immunotherapy in lung cancer. He received his medical degree from Johns Hopkins University School of Medicine, and completed fellowships at Harvard Medical School, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College. 

    Dr. Hellman is a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. He is dedicated to identifying better treatments for people with all stages of disease and to providing compassionate care for patients and their families. His research focuses on developing innovative and effective ways to harness the body’s immune system to fight cancer, and he is a member of the Immunotherapeutics Group, where >span class="TextRun SCXW191243763 BCX0"> design and lead early-phase clinical trials of immunotherapies for patients with a variety of different cancers. 

    Jamie Holloway, PhD

    Senior Director of the Molecular Science Liaisons, Caris Life Sciences

    Jamie Holloway is the Senior Director of the Molecular Science Liaisons at Caris Life Sciences, where she leads a team of field-based PhD-trained scientists who act as a resource for any technical, clinical, or research discussions for oncologists within their region. 

    Prior to joining Caris Life Sciences, Jamie worked in patient engagement and built an extensive network within cancer patient advocacy communities. She worked in patient engagement at Cure Forward, Science 37, and the Metastatic Breast Cancer Project at the Broad Institute. She is an active volunteer, having served on high level committees within AACR, ASCO, Friends of Cancer Research, and the NCCN. 

    Dr. Holloway earned her bachelor’s degree from the University of Illinois and her PhD from Georgetown University, where she studied the interaction of growth factor signaling and estrogen receptor expression in breast cancer. 

    Angela Stover, PhD

    Assistant Professor, UNC Gillings School of Global Public Health

    Dr. Stover is an Assistant Professor of Health Policy and Management at the University of North Carolina at Chapel Hill. Dr. Stover is a translational health outcomes researcher who uses implementation science to implement and evaluate patient-reported outcomes (PROs) in cancer care settings. She conducted foundational work developing implementation science metrics for evaluating PRO implementation initiatives (Stover, QOLR 2020). Her implementation work builds on PRO development work for six of the NIH PROMIS® item banks assessing depression, anxiety, and poor sleep (U01-AR052155) and other PROs. Dr. Stover teaches the graduate course on PROs and use in health care delivery in the Gillings School of Global Public Health (course code: HPM 794).  

    Dr. Stover is a co-investigator on a pragmatic trial (PCORI IHS-1511-33392) examining whether 1,200 chemotherapy patients treated in 52 community oncology practices who are randomized to a home PRO intervention have better survival and quality of life, and fewer ER visits than usual care. Dr. Stover led analyses showing that cancer patients who elected to complete their weekly home PROs through an automated call were more likely to be from underserved cancer populations (older, people of color, rural, and a high school education) and had a higher symptom burden than cancer patients who chose email. These findings have important implications for clinics implementing PROs to ensure equitable access to symptom monitoring. 

    Theresa Walnus, PhD

    Associate Professor, Northwestern University Feinberg School of Medicine

    Dr. Walnus is the Associate Director for the Center for Health Information Partnerships and Director of the Chicago Health IT Regional Extension Center. She received her PhD in immunology from the University of Chicago, where she discovered the function of CTLA-4, the first checkpoint inhibitor. Following her MS in computer science, she worked in microbial genomics developing informatics tools to understand biochemical pathways in microorganisms. She joined the Nortwestern faculty to focus on medical informatics.  

    Dr. Walunas goal is to improve health for people with autoimmune diseases, using immunological, genomics, informatics, and implementation science methods to study the development of autoimmunity. Her research focuses on using electronic health recordsintersected with genetic, social and environmental datato develop translational models to elucidate the molecular and environmental mechanisms of human autoimmune disease and develop EHR-based tools to improve care for people with autoimmunity. 

    Eliezer Van Allen, MD

    Associate Professor of Medicine, Harvard Medical School

    Dr. Van Allen is an Associate Professor of Medicine at Harvard Medical School, a clinician at Dana-Farber/Partners Cancer Care, and an Associate Member at the Broad Institute of MIT and Harvard. His research focuses on computational cancer genomics, the application of new technologies such as massively parallel sequencing to precision cancer medicine, and resistance to targeted therapeutics. As both a computational biologist and medical oncologist, he has specific expertise in clinical computational oncology and the development of algorithms to analyze and interpret genomic data for clinically focused questions. Overall, his research will make important contributions to the field of precision cancer medicine and resistance to targeted therapeutics via expertise and study in translational and clinical bioinformatics. Originally from Los Angeles, CA, he studied Symbolic Systems at Stanford University, obtained his medical degree from UCLA, and completed a residency in internal medicine at UCSF before coming to Boston and completing a medical oncology fellowship at the Dana-Farber/Partners Cancer Care program. 

    Raju Vaddepally, MD (Moderator)

    Oncologist, Yuma Medical Center

    Dr. Vaddepally received his medical degree at Osmania Medical College, affiliated with N.T.R. University of Health Sciences in Hyderabad, India. He completed his residency in internal medicine from St. Joseph Mercy Hospital in Ann Arbor, Michigan. During his residency he developed an immense interest in taking care of cancer patients which motivated him to pursue additional training in oncology and hematology. Dr. Vaddepally completed a fellowship in hematology and oncology at Josephine Ford Cancer Institute at Henry Ford Hospital, which is affiliated with Wayne State University in Detroit, MI. Dr. Vaddepally is a member of the American Society of Hematology and American Society of Clinical Oncology. He is also a member of the American College of Physicians.

    Dr. Vaddepally was born in India. He moved to Yuma with his wife, who is a pediatrician, and young daughter. In his spare time, Dr. Vaddepally enjoys photography, traveling, tennis and racquetball. 

    Matthew R. Zibelman, MD (Moderator)

    Assistant Professor, Department of Hematology/Oncology Fox Chase Cancer Center

    Dr. Zibelman is a medical oncologist specializing in the treatment of genitourinary cancers. He understands that the patient-oncologist relationship is a unique partnership and that the cancer journey provides access to moments in life that can be emotionally challenging for all parties. He views his role as one that is ultimately about providing information and guidance to help navigate the path in the way best suited to each patient. 

    Dr. Zibelman finds genitourinary oncology a particularly satisfying and exciting field within medical oncology as it is an area of robust, active research, which has afforded new treatment options for patients. Dr. Zibelman completed his oncology training at Fox Chase. 

  • Contains 3 Component(s)

    This webinar will address high-level information related to coding and billing for oncology services. Learn how coding and billing varies by the care delivery setting where the services are performed, geographic location of those services, and payer policies. Common terminology related to coding and billing of oncology outpatient services will be reviewed, how these terms apply to various settings, and related resources. The webinar includes an Interactive Q&A with the speaker and attendees.

    This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.  

     If You DO NOT Have an ACCC Account: 

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page. 
    • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.  
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.  
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link. 
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course! 

    If You Have an ACCC Account: 

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button. 
    • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course! 

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!  

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar. 

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    This webinar will address high-level information related to coding and billing for oncology services. Learn how coding and billing varies by the care delivery setting where the services are performed, geographic location of those services, and payer policies. Common terminology related to coding and billing of oncology outpatient services will be reviewed, how these terms apply to various settings, and related resources. The webinar includes an Interactive Q&A with the speaker and attendees.

    Teri Bedard, BA, RT(R)(T), CPC

    Director, Client Services

    Revenue Cycle Coding Strategies, Inc.

    Teri Bedard is the Executive Director, Client & Corporate Resources with Revenue Cycle Coding Strategies, Inc.  Her expertise includes over 20 years of medical experience.  Teri has served as a senior and Staff Radiation Therapist at renowned oncology practices across the Midwest and during her tenure with RCCS, has served as a Senior Consultant, Remote Solutions Manager, and Director, Client Services.   As a member of the RCCS team Teri advises and leads clients in the areas of billing and reimbursement for technology, monitoring government regulatory information and seeking new business opportunities.    

    Teri completed her Bachelors of Arts degree at the University of Northern Iowa.  She completed her Radiologic Technology certificate at Mayo School for Health Related Sciences in Rochester, MN and her certificate for Radiation Therapy at Fairview University Medical Center in Minneapolis, MN.  She also earned her certification as a Certified Professional Coder (CPC) through the American Academy of Professional Coders (AAPC). 

    Teri is active in the ARRT, ASRT, and AAPC.  She lectures and participates at national seminars in conjunction with the AAPC, ACCC, ACRO, and ASRT.  

    Kristin Ferguson, DNP, RN, OCN (Moderator)

    Senior Director, Cancer Care Delivery & Health Policy, Association of Community Cancer Centers

    Kristin Marie Ferguson, DNP, RN, OCN, is Senior Director, Cancer Care Delivery & Health Policy at ACCC. Together with engaged volunteer leadership and committed professional staff, the Department of Cancer Care Delivery & Health Policy works towards improving cancer care delivery in all settings, supporting the oncology workforce, and transforming reimbursement for cancer care delivery so that the needs of patients and professionals are met.

    Dr. Ferguson has over a decade of oncology nursing experience. Prior to working with ACCC, she worked at MedStar Georgetown University Lombardi Cancer Center as the Clinical Operations Manager. She is currently on the national Board of Directors for the Oncology Nursing Society. Dr. Ferguson has spoken and taught nationally and internationally on the topics of cancer, nursing leadership, and health care coordination.

    Dr. Ferguson received her Bachelor of Science in Nursing from Boston College, her Master of Science in Nursing: Community/Public Health from Catholic University of America, and her Doctorate in Nursing Practice from Duke University.

;